Alger Russell Innovation ETF (INVN)
NYSEARCA: INVN · Real-Time Price · USD
19.27
+0.37 (1.97%)
At close: Feb 24, 2026, 4:00 PM EST
19.27
0.00 (0.00%)
After-hours: Feb 24, 2026, 8:00 PM EST
1.97% (1D)
| Assets | $10.87M |
| Expense Ratio | 0.55% |
| PE Ratio | 19.22 |
| Shares Out | 575,000 |
| Dividend (ttm) | $0.06 |
| Dividend Yield | 0.32% |
| Ex-Dividend Date | Dec 18, 2025 |
| Payout Frequency | n/a |
| Payout Ratio | 6.30% |
| Volume | 5,026 |
| Open | 19.26 |
| Previous Close | 18.90 |
| Day's Range | 19.23 - 19.27 |
| 52-Week Low | 15.37 |
| 52-Week High | 22.34 |
| Beta | n/a |
| Holdings | 51 |
| Inception Date | Jan 6, 2025 |
About INVN
Fund Home PageThe Alger Russell Innovation ETF (INVN) is an exchange-traded fund that is based on the Alger Russell Innovation index. The fund tracks an equal-weighted index of 50 US stocks selected from the Russell 1000 through a fundamental approach. The fund seeks to identify companies at the forefront of innovation. INVN was launched on Jan 6, 2025 and is issued by Alger.
Asset Class Equity
Category Mid-Cap Blend
Region North America
Stock Exchange NYSEARCA
Ticker Symbol INVN
ETF Provider Alger
Index Tracked Alger Russell Innovation Index
Top 10 Holdings
27.25% of assets| Name | Symbol | Weight |
|---|---|---|
| Enphase Energy, Inc. | ENPH | 3.66% |
| Merck & Co., Inc. | MRK | 2.75% |
| Bristol-Myers Squibb Company | BMY | 2.73% |
| RingCentral, Inc. | RNG | 2.68% |
| Cirrus Logic, Inc. | CRUS | 2.66% |
| Align Technology, Inc. | ALGN | 2.65% |
| BioMarin Pharmaceutical Inc. | BMRN | 2.63% |
| F5, Inc. | FFIV | 2.54% |
| Organon & Co. | OGN | 2.47% |
| Regeneron Pharmaceuticals, Inc. | REGN | 2.47% |
Performance
INVN had a total return of -2.09% in the past year, including dividends. Since the fund's inception, the average annual return has been -2.99%.
